z-logo
Premium
Identifying a candidate population for ovarian conservation in young women with clinical stage IB–IIB cervical cancer
Author(s) -
Matsuo Koji,
Shimada Muneaki,
Yamaguchi Satoshi,
Kanao Hiroyuki,
Nakanishi Toru,
Saito Toshiaki,
Kamiura Shoji,
Iwata Takashi,
Mikami Mikio,
Sugiyama Toru
Publication year - 2017
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.31084
Subject(s) - stage (stratigraphy) , cervical cancer , ovarian cancer , gynecology , medicine , oncology , population , cancer , obstetrics , biology , environmental health , paleontology
This study seeks to identify risk factors associated with ovarian metastasis and to characterize a population with minimum risk of ovarian metastasis in young women with stage IB–IIB cervical cancer. This was a nation‐wide multicenter retrospective study in Japan examining consecutive cases of surgically‐treated women with clinical stage IB–IIB cervical cancer who had oophorectomy at radical hysterectomy ( n  = 5,697). Multivariable analysis was performed to identify independent risk factors for ovarian metastasis. Ovarian metastasis was seen in 70 (1.2%, 95% confidence interval 0.9–1.5) cases. In the entire cohort, adenocarcinoma, lympho‐vascular space invasion, uterine corpus tumor invasion, and pelvic/para‐aortic nodal metastases remained independent risk factors for ovarian metastasis (all, adjusted‐ p  < 0.05). In a sensitivity analysis of 3,165 women aged <50 years (ovarian metastasis, 1.0%), adenocarcinoma, parametrial tumor involvement, uterine corpus tumor involvement, and pelvic/para‐aortic nodal metastases remained independent risk factors for ovarian metastasis (all, adjusted‐ P  < 0.05). In the absence of these five risk factors (representing 46.1% of women aged <50 years), the incidence of ovarian metastasis was 0.14%. With the presence of adenocarcinoma alone (representing 18.9% of women aged <50 years), the incidence of ovarian metastasis was 0.17% and was not associated with increased risk of ovarian metastasis compared to the subgroup without any risk factors ( p  = 0.87). In conclusion, nearly two thirds of women aged <50 years with clinical stage IB–IIB cervical cancer had no risk factor for ovarian metastasis or had adenocarcinoma alone: these subgroups had ovarian metastasis rates of around 0.1% and may be a candidate population for ovarian conservation at surgical treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom